HeyFlow, a female reproductive health inclusion business aiming to end workplace disadvantages for women, has secured a £235,000 investment from Aer Venture Studios. This funding will support the development and architecture of HeyFlow’s tech platform and employee insight product, enabling the company to expand its reach to more enterprise clients both nationally and globally. HeyFlow is the inaugural investment client for Aer…
U-Ploid, a venture-backed biotech company, has introduced its new platform designed to enhance the quality of older egg cells, a critical factor in increasing the success rates of in vitro fertilization (IVF) for women experiencing age-related infertility. The company’s technology aims to repair decades of accumulated damage in eggs, thereby improving their viability during IVF treatments. Age-related fertility decline affects millions worldwide,…
Organon China has announced a licensing and supply agreement with Shanghai Bao Pharmaceutical (BaoPharma) and its wholly-owned subsidiary, Suzhou Centergene Pharmaceuticals. Through this partnership, Organon acquires the exclusive commercialization rights to Centergene’s investigational asset, SJ02, in Mainland China. SJ02, developed by Centergene, is a long-acting recombinant human follicle-stimulating hormone carboxyl-terminal peptide fusion protein (FSH-CTP). It is designed for controlled ovarian stimulation (COS)…
Femasys, a biomedical company specializing in women’s health, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for FemChec, adiagnostic tool for checking the fallopian tubes. This new solution is designed for controlled delivery of contrast media, allowing for clearer confirmation of tubal status during ultrasound evaluations. Kathy Lee-Sepsick, founder and CEO of Femasys,…
CooperSurgical has introduced a new single-hand inserter for its Paragard intrauterine copper contraceptive (IUD). Recently approved by the U.S. Food and Drug Administration (FDA), this new inserter is designed to simplify the insertion process, making Paragard more accessible for healthcare providers and patients. Paragard has been a trusted option for over 30 years, offering more than 99% efficacy in preventing pregnancy for…
HANX, the UK-based sexual wellness and intimate care brand, has announced a significant expansion of its digital pharmacy services with the introduction of GLP-1 medications, marking its evolution into the broader femtech category. The new weight management offering is designed to support women struggling with conditions like Polycystic Ovary Syndrome (PCOS), endometriosis, and menopause. The GLP-1 medications, Mounjaro (tirzepatide) and Wegovy (semaglutide),…
Tennis legend Maria Sharapova has joined Cofertility as their newest investor, bringing her influence and financial backing to the startup. Cofertility aims to make egg freezing more accessible and affordable by linking it with egg donation, offering women the opportunity to freeze their eggs for free when they donate half to intended parents who are unable to conceive. Sharapova, who retired from…
Aetna, a CVS Health company, is now the first major insurer in the US to include intrauterine insemination (IUI) as a covered medical benefit for all eligible plans. This new coverage will be available beginning September 1, 2024, and aims to increase access to fertility services for a broader range of individuals, regardless of sexual orientation or partner status. Previously, coverage for…
